Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controlling cardiomyocyte survival.

Nicolaas de Jonge1, Marie Jose Goumans, Daan Lips

  • 1Department of Cardiology, Heart Lung Center Utrecht, UMC Utrecht, The Netherlands.

Novartis Foundation Symposium
|October 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a basic robotic training course for residents in general surgery in the Netherlands.

Digestive surgery·2026
Same author

SHH Variant in a Father and a Son with Tracheobronchial Malformation.

Molecular syndromology·2026
Same author

Intraoperative sodium range affects white matter microstructure in neonatal congenital heart disease.

International journal of cardiology. Congenital heart disease·2026
Same author

Corrigendum to Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance.

The Journal of clinical investigation·2026
Same author

Perioperative Monitoring of Regional Oxygen Saturation in Congenital Heart Disease: Systematic Review of Literature up to 2023.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2026
Same author

Postnatal and postinterventional cerebral Doppler ultrasound in neonates with critical congenital heart disease.

The Journal of thoracic and cardiovascular surgery·2025
Same journal

Genetic and therapeutic control of diabetogenic CD8+ T cells.

Novartis Foundation symposium·2009
Same journal

Translating mucosal antigen based prevention of autoimmune diabetes to human.

Novartis Foundation symposium·2009
Same journal

Re-establishing immune tolerance in type 1 diabetes via regulatory T cells.

Novartis Foundation symposium·2009
Same journal

Immune markers of disease and therapeutic intervention in type 1 diabetes.

Novartis Foundation symposium·2009
Same journal

Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass.

Novartis Foundation symposium·2009
Same journal

CD8 and cytotoxic T cells in type 1 diabetes.

Novartis Foundation symposium·2009
See all related articles

Cardiomyocyte survival pathways, including hypertrophy and apoptosis signaling, are interconnected. Targeting these pathways, like ERK and Akt, can protect heart cells from ischemic damage and preserve cardiac function.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Cellular Signaling

Background:

  • Signaling pathways for hypertrophy, cell cycle control, apoptosis, and cell survival are increasingly recognized as interconnected.
  • Cardiomyocytes have a blocked cell cycle, shifting focus to hypertrophy pathways for ischemic models.
  • Understanding cell fate determination by stimuli and microenvironment is crucial.

Purpose of the Study:

  • To investigate the protective effects of various interventions on cardiomyocyte loss and function.
  • To explore the role of specific signaling pathways, such as MAPK and Akt, in preventing cardiac damage.
  • To highlight the importance of assessing both cell death and myocardial function.

Main Methods:

  • Review of studies involving growth factors (IGF1, FGF1,2) and downstream signaling interventions.

Related Experiment Videos

  • Analysis of gene-targeted mouse models with specific pathway activations (e.g., ERK, Akt).
  • Emphasis on the need for improved molecular imaging techniques for cardiomyocyte death assessment.

    • Main Results:

    • Growth factors and downstream pathway interventions demonstrate cardiomyocyte protection in vitro and in vivo.
    • Constitutive activation of ERK proteins prevents ischemic heart damage and preserves left ventricular function.
    • Nuclear Akt plays a key role in preventing apoptosis, supported by genetic and pharmacological evidence.

    Conclusions:

    • Interventions targeting interconnected signaling pathways offer cardioprotection against ischemic injury.
    • ERK and Akt pathways are critical targets for preventing cardiomyocyte loss and maintaining cardiac function.
    • Accurate assessment of myocardial function alongside cell death measurement is essential for evaluating adaptive vs. maladaptive responses.